Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kian Ang

Showing results (41-50 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapyEiko Nakata, Nancy Hunter, Kathy Mason, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2006
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumorsKathryn A Mason, Robert Neal, Nancy Hunter, et al.
Head & Neck|December 25, 2008
Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinomaAndre A Konski, Kathryn Winter, Bernard F Cole, et al.
Investigational New Drugs|February 2, 2010
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivoMylin A Torres, Uma Raju, David Molkentine, et al.
International Journal of Clinical Oncology|April 20, 2007
Combination of radiotherapy with EGFR antagonists for head and neck carcinomaJuliette Thariat, Gokcen Yildirim, Kathryn A Mason, et al.
Anticancer Research|July 31, 2012
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiationFumihiko Matsumoto, David N Valdecanas, Kathryn A Mason, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Modulation of rodent spinal cord radiation tolerance by administration of platelet-derived growth factorNicolaus H Andratschke, Carsten Nieder, Roger E Price, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinomaXiaochun Wang, Xiaodong Zhang, Lei Dong, et al.
Seminars in Radiation Oncology|April 20, 2004
Target coverage for head and neck cancers treated with IMRT: review of clinical experiencesAdam S Garden, William H Morrison, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiationLuka Milas, Fu-Min Fang, Kathy A Mason, et al.
Pageof 21

Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapyEiko Nakata, Nancy Hunter, Kathy Mason, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2006
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumorsKathryn A Mason, Robert Neal, Nancy Hunter, et al.
Head & Neck|December 25, 2008
Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinomaAndre A Konski, Kathryn Winter, Bernard F Cole, et al.
Investigational New Drugs|February 2, 2010
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivoMylin A Torres, Uma Raju, David Molkentine, et al.
International Journal of Clinical Oncology|April 20, 2007
Combination of radiotherapy with EGFR antagonists for head and neck carcinomaJuliette Thariat, Gokcen Yildirim, Kathryn A Mason, et al.
Anticancer Research|July 31, 2012
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiationFumihiko Matsumoto, David N Valdecanas, Kathryn A Mason, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Modulation of rodent spinal cord radiation tolerance by administration of platelet-derived growth factorNicolaus H Andratschke, Carsten Nieder, Roger E Price, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinomaXiaochun Wang, Xiaodong Zhang, Lei Dong, et al.
Seminars in Radiation Oncology|April 20, 2004
Target coverage for head and neck cancers treated with IMRT: review of clinical experiencesAdam S Garden, William H Morrison, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiationLuka Milas, Fu-Min Fang, Kathy A Mason, et al.
Pageof 21